Literature DB >> 17418660

The status of US allergy/immunology physicians in the 21st century: a report from the American Academy of Allergy, Asthma & Immunology Workforce Committee.

Gailen D Marshall1.   

Abstract

The American Academy of Allergy, Asthma & Immunology has tracked the US allergy/immunology physician workforce (AIPW) over the past 3 decades by funding 2 workforce surveys (1999, 2004). Results have demonstrated both accomplishments of and challenges for the US AIPW. Accomplishments include increases in diversity (25% women in 2004, 20% in 1999, 10% in 1989; 6% underrepresented minorities in 2004, 5% in 1999), 95% of AIPW has completed an allergy/immunology (A/I) training program, and 91% are American Board of Allergy and Immunology (a conjoint board of the American Board of Internal Medicine and the American Board of Pediatrics)-certified (90% in 1999). Training positions and program numbers are slowly increasing, and numbers of new graduates from accredited A/I programs have also increased. We are seeing patients with more complex allergic and immune diseases and giving less allergen immunotherapy. Personal, professional, and economic satisfaction is increasing. Challenges relate primarily to diminishing practitioner supply (4245 in 2004 vs 4356 in 1999) amid growing US population demand. The AIPW is gradually aging (the average age is 53 years in 2004, compared with 51 years in 1999) and working longer before retiring. The combination of job satisfaction, the high demand for A/I services, and the large number of fellowship applicants all support expanding the supply of trained allergists/immunologists.

Entities:  

Mesh:

Year:  2007        PMID: 17418660     DOI: 10.1016/j.jaci.2007.01.040

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  5 in total

Review 1.  Controversies in Drug Allergy: Drug Allergy Pathways.

Authors:  Anca M Chiriac; Aleena Banerji; Rebecca S Gruchalla; Bernard Y H Thong; Paige Wickner; Paul-Michel Mertes; Ingrid Terreehorst; Kimberly G Blumenthal
Journal:  J Allergy Clin Immunol Pract       Date:  2018-12-17

2.  Diagnosis and treatment of allergic diseases in Zhejiang Province: a cross-sectional survey.

Authors:  Hui-ying Wang; Yi-hong Shen; Xu-yan Yang; Lan-fang Tang; Jian-ying Zhou
Journal:  J Zhejiang Univ Sci B       Date:  2015-07       Impact factor: 3.066

Review 3.  Role of clinical history in beta-lactam hypersensitivity.

Authors:  Jessica Plager; Allen Judd; Kimberly Blumenthal
Journal:  Curr Opin Allergy Clin Immunol       Date:  2021-08-01

Review 4.  COVID-19: Pandemic Contingency Planning for the Allergy and Immunology Clinic.

Authors:  Marcus S Shaker; John Oppenheimer; Mitchell Grayson; David Stukus; Nicholas Hartog; Elena W Y Hsieh; Nicholas Rider; Cullen M Dutmer; Timothy K Vander Leek; Harold Kim; Edmond S Chan; Doug Mack; Anne K Ellis; David Lang; Jay Lieberman; David Fleischer; David B K Golden; Dana Wallace; Jay Portnoy; Giselle Mosnaim; Matthew Greenhawt
Journal:  J Allergy Clin Immunol Pract       Date:  2020-03-26

5.  Reducing Delays in Diagnosing Primary Immunodeficiency Through the Development and Implementation of a Clinical Decision Support Tool: Protocol for a Quality Improvement Project.

Authors:  Bharat Kumar; Samuel Zetumer; Melissa Swee; Ellen L Keyser Endelman; Manish Suneja; Benjamin Davis
Journal:  JMIR Res Protoc       Date:  2022-01-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.